Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis.
about
PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicityThe staphylococcal enterotoxin (SE) family: SEB and siblingsThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodiesChimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.Neutralization of staphylococcal enterotoxin B by an aptamer antagonistAn engineered innate immune defense protects grapevines from Pierce disease.Barrier function of the nasal mucosa in health and type-2 biased airway diseases.Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigensTherapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.S101, an Inhibitor of Proliferating T Cells, Rescues Mice From Superantigen-Induced Shock.
P2860
Q26825729-4AC3D5D2-4F07-44B9-9AF1-6AF423D452CDQ26830220-68187C29-F487-4F71-A24A-862A423B9DC3Q30415990-0ED79A1E-8CB2-453C-8FC0-8E5E224039BBQ33877190-4FC98049-D0BA-4954-A3BE-F24F26BB2590Q34079264-201F984C-6984-4FCD-93BB-1A9905D40B3BQ34301653-D5109645-4C69-44C2-AD2A-ADA135B1778EQ35169108-CE951033-BB3F-49A8-9757-B3707FB811E0Q35845047-7740CD60-C94F-4D69-A61C-73970044044FQ35852413-11DF0742-1655-4918-92B0-147AF37038ABQ37235247-E7C60C58-7BC7-4129-897F-309AB1D9F3D4Q37501623-21EF7914-742D-4F03-8DC2-7D496971E089Q37617797-31BB28E0-88B4-4A92-AA06-1ED2D5341FADQ37954312-CD2C3D59-588E-4F59-82C8-BCAE1FD741B3Q49921647-575E0C99-3162-4B3D-A63A-60A5495CD632
P2860
Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Design of chimeric receptor mi ...... of superantigen pathogenesis.
@en
type
label
Design of chimeric receptor mi ...... of superantigen pathogenesis.
@en
prefLabel
Design of chimeric receptor mi ...... of superantigen pathogenesis.
@en
P2093
P2860
P356
P1476
Design of chimeric receptor mi ...... of superantigen pathogenesis.
@en
P2093
Elizabeth Hong-Geller
Goutam Gupta
Margit Möllhoff
Patrick R Shiflett
P2860
P304
P356
10.1074/JBC.M309388200
P407
P577
2003-11-06T00:00:00Z